Pharmacogenomics (PGx) involves the study of patients’ unique genes to predict their individual response to drugs. 1,3 In assessments of the 12 most important pharmacogenes, at least 1 clinically ...

America prescribes more than 4 billion drugs each year, and half of them aren't even working. The CEO of a leading pharmacogenomics firm shares his thoughts about a new cure to this issue and what it ...

Our Pharmacogenomics and Transport micro-credential is a three-course series encompassing several aspects of pharmacogenomics from transport to current events incorporating cancer and nutrition. Each ...

SAN JOSE, Calif.--(BUSINESS WIRE)--YuJa Inc. is pleased to announce a site-wide lecture capture initiative with Manchester University, a private university in North Manchester, Indiana to provide ...

The concept of “personalized medicine” has gone from the traditional idea of a physician making a diagnosis and prescribing a medication to the next step: how the patient interacts with that ...

Will the genomic revolution deliver a brave new world of gene-based medicine, complete with personal genomes on chips, predictive disease profiling, and gene therapy? Not all the great expectations ...

Aware of this aspect, the pharmaceutical industry has recently started to implement pharmacogenomics into the drug-development pipeline by correlating quantitative measures derived from ...

In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system delves into the multifaceted implementation of pharmacogenomics-a rapidly evolving field ...

As part of this initiative, PGxAI will roll out a suite of pharmacogenomic reports on Sequencing.com that provide personalized drug implications based on an individual’s genomic data. They directly ...

ROCHESTER, Minn.-- Mayo Clinic researchers have used pharmacogenomics to develop a test and treatment for an inherited kidney disorder that can cause organ failure in children and young adults. The ...